| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |